Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Cell-Based Therapy
  • Published:

Cell-Based Therapy

Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity

Abstract

We have developed a culture method for the foreign serum-free generation of highly immunostimulatory, CD83+ human dendritic cells (DC). In this study, we evaluated the feasibility and consequences of endogenously expressing antigens in mature DC using adenoviral vectors. Transduction of DC with Ad-EGFP demonstrated endogenous fluorescence in 50–85% of CD83+ DC. Ad-transduced DC stimulated the proliferation of allogeneic CD8+ and CD4+ T cells at low DC: T cell ratios. However, at high DC: T cell ratios the stimulatory capacity of Ad-transduced DC was suppressed. This immunosuppressive effect was confirmed by demonstrating that the stimulatory function of untreated DC could be suppressed in a dose-dependent manner by addition of Ad-transduced DC. Furthermore, transwell experiments suggested that direct cell contact was required. Taken together, our results demonstrate the feasibility of efficiently expressing antigens in CD83+ DC using adenoviruses. However, immunosuppressive effects must be considered and carefully studied before Ad-transduced DC are employed for clinical trials.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Banchereau J, Steinman RM . Dendritic cells and the control of immunity Nature 1998 392: 245–252

    Article  CAS  PubMed  Google Scholar 

  2. Romani N et al. Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability J Immunol Meth 1996 196: 137–151

    Article  CAS  Google Scholar 

  3. Jonuleit H et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions Eur J Immunol 1997 27: 3135–3142

    Article  CAS  PubMed  Google Scholar 

  4. Schuler G, Steinman RM . Dendritic cells as adjuvants for immune-mediated resistance to tumors J Exp Med 1997 186: 1183–1187

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. van Elsas A et al. Peptide-pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA-A*0201-binding peptides from the Melan-A/MART-1 self antigen Eur J Immunol 1996 26: 1683–1689

    Article  CAS  PubMed  Google Scholar 

  6. Nestle FO et al. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells Nature Med 1998 4: 328–332

    Article  CAS  PubMed  Google Scholar 

  7. Tüting T, DeLeo AB, Lotze MT, Storkus WJ . Genetically modified bone marrow-derived dendritic cells expressing tumor-associated viral or ‘self’ antigens induce antitumor immunity in vivo Eur J Immunol 1997 27: 2702–2707

    Article  PubMed  Google Scholar 

  8. Specht JM et al. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases J Exp Med 1997 186: 1213–1221

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Song W et al. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity J Exp Med 1997 186: 1247–1256

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wan Y et al. Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination Hum Gene Ther 1997 8: 1355–1363

    Article  CAS  PubMed  Google Scholar 

  11. Gong J et al. Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells Gene Therapy 1997 4: 1023–1028

    Article  CAS  PubMed  Google Scholar 

  12. Perez-Diez A et al. Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene Cancer Res 1998 58: 5305–5309

    CAS  PubMed  Google Scholar 

  13. De Veerman M et al. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity J Immunol 1999 162: 144–151

    CAS  PubMed  Google Scholar 

  14. Arthur JF et al. A comparison of gene transfer methods in human dendritic cells Cancer Gene Ther 1997 4: 17–25

    CAS  PubMed  Google Scholar 

  15. Labeur MS et al. Generation of tumor immunity by bone marrow-derived dendritic cells correlates with dendritic cell maturation stage J Immunol 1999 162: 168–175

    CAS  PubMed  Google Scholar 

  16. Mackey MF et al. Dendritic cells require maturation via CD40 to generate protective antitumor immunity J Immunol 1998 161: 2094–2098

    CAS  PubMed  Google Scholar 

  17. Brossart P et al. Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte–macrophage colony-stimulating factor Blood 1998 92: 4238–4247

    CAS  PubMed  Google Scholar 

  18. Tillman BW et al. Maturation of dendritic cells accompanies high-efficiency gene transfer by a CD40-targeted adenoviral vector J Immunol 1999 162: 6378–6383

    CAS  PubMed  Google Scholar 

  19. Diao J et al. Human PBMC-derived dendritic cells transduced with adenovirus vector induce cytotoxic T-lymphocyte responses against vector-encoded antigen in vitro Gene Therapy 1999 6: 845–849

    Article  CAS  PubMed  Google Scholar 

  20. Hardy S et al. Construction of adenovirus vectors through Cre–lox recombination J Virol 1997 71: 1842–1849

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by grants No. SFB-432 (to AE) and Tu90/2-1 (to TT) from the Deutsche Forschungsgemeinschaft.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jonuleit, H., Tüting, T., Steitz, J. et al. Efficient transduction of mature CD83+ dendritic cells using recombinant adenovirus suppressed T cell stimulatory capacity. Gene Ther 7, 249–254 (2000). https://doi.org/10.1038/sj.gt.3301077

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3301077

Keywords

This article is cited by

Search

Quick links